Announcements

TecTraum Announces American Medical Association Issuing of First Ever Category III CPT Code for Treating Concussions

TecTraum Inc. announces today that the American Medical Association (AMA) has issued a new Category III Current Procedural Terminology (CPT®) code to help clinicians treat sports-related concussion symptoms with its flagship technology, pro2cool®.

TecTraum Announces Completion of Multisite Clinical Trial Using pro2cool® Device for the Treatment of Concussions

TecTraum Inc., dedicated to providing the world’s first point-of-care treatment for concussions, announced complete enrollment status for a clinical trial that began in fall of 2019 using its flagship technology, pro2cool®.

pro2cool FDA designated breakthrough device

TecTraum’s pro2cool® Receives FDA Designation as a Breakthrough Device for the Treatment of Concussions

TecTraum Inc., dedicated to providing the world’s first point-of-care treatment for concussions, today announced that the U.S. Food and Drug Administration (FDA) has designated its flagship technology, pro2cool®, as a Breakthrough Device.